Escherichia coli contains two AP endonucleases that cleave 5' to AP sites, exonuclease III (22) and endonuclease IV (15) . Other lesions recognized by these enzymes are a group of 3' blocked termini including 3'-phosphates and 3'-phosphoglycolate esters (7, 10) . Urea-N-glycosides are endonucleolytically attacked by exonuclease III (11) , whereas endonuclease IV preferentially attacks modified AP sites created by bleomycin and neocarzinostatin (19, 20) . Exonuclease III is the major activity in uninduced cells (16) , whereas endonuclease IV can be induced by agents that generate superoxide radical ions (3) . Experiments with mutants deficient in either or both of these enzymes suggest that endonuclease IV plays a relatively minor role in the repair of alkylation damage and the repair of AP sites but plays a major role in the recovery of cells treated with bleomycin and t-butyl hydroperoxide (5) . These differences may be explained by nonoverlapping enzymatic activities or by differences in the genetic structure and regulation of the genes coding for these enzymes. We have sequenced the xth gene (26) and the nfo gene to understand the structure and function of the genes and gene products.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All experiments were performed with E. coli RPC51 except for maxicell analysis, which was performed with strain DR1984 (24) . RPC51 has the following genotype: endA thi hsdR A(srlRrecA)306. Subcloning was done in the plasmid pBR322. A derivative of pBR325 was used for maxicell analysis. Plasmid pUC4K (30) was the source of a restriction fragment containing a gene specifying kanamycin resistance. Media and growth of cells were as previously described (4 DNA substrate and AP endonuclease assay. 3H-labeled partially depyrimidinated T4 phage DNA (6) and sonicates of log-phase cells were prepared and diluted as previously described (5) . The acid solubility assay for endonuclease IV was performed as described by Cunningham et al. (5) .
Analysis of plasmid-specific proteins. Maxicell analysis of plasmid-coded proteins was performed by the procedure of Sancar et al. (23) as described by Rodriguez and Tait (21) .
Nucleotide sequencing. Restriction fragments of plasmid pRPC124 and its deletion derivatives were subcloned into M13 sequencing vectors (18) mpl8, mpl9, um20, and um2l. Single-stranded DNA template DNA was prepared according to the International Biotechnologies sequencing manual. Nucleotide sequence was determined by the dideoxy-chain termination method (25, 28) . Nucleotide sequences were compiled and analyzed with the gel reader and the IBI/ Pustell DNA and protein sequence analysis system from International Biotechnologies.
Isolation and manipulation of DNA. Plasmids were amplified with chloramphenicol or spectinomycin and purified by a modified alkaline lysis procedure (1). The conditions for restriction endonuclease and BAL 31 exonuclease digestion were those suggested by the manufacturers. DNA linkers were added as previously described (27) . Partial digestion of plasmids was accomplished by removing samples from a standard reaction at various times and stopping the reaction with excess trisodium EDTA. The products from partial or complete restriction digestions were separated on agarose gels, and the appropriate fragments were excised and purified with the Geneclean kit (Bio 101, Inc.). The ligation of linear plasmid molecules after the addition of linkers, ligation of DNA fragments into a cleaved vector (17) , and DNA transformation into calcium-treated cells (21) were previously described.
Isolation of RNA and primer extension. The isolation of cellular RNA and primer extension of cellular RNA has been previously described (26) .
Other methods. Protein concentrations were determined by the method of Bradford (2) . Fig. 3 . A DNA sequence of 1,020 nucleotides including the nfo gene is shown in Fig. 4 promoter recognized by the c0 subunit of RNA polymerase (9) . A potential ribosome-binding site of AGGAG was found at nucleotides 70 through 74, seven bases away from the initiation codon. There was no region of dyad symmetry 3' to the stop codon, which would be expected of a transcriptional terminator. There was a start codon at nucleotides 942 through 944 followed by an ORF that extends to the end of the sequenced fragment. This ORF also had a codon usage consistent with the nonrandom codon usage found in E. coli genes.
RESULTS

Subcloning
The ORF from nucleotides 82 to 937 would code for a polypeptide of 285 amino acids with a calculated molecular mass of 31,562 Da, which is consistent with the values derived from analysis of the purified protein and also consistent with the value we determined from maxicell analysis. The N-terminal amino acid sequence of endonuclease IV has been determined for the first six amino acids (13) and is in perfect agreement with our predicted sequence. The amino acid composition of endonuclease IV has been determined (B. Demple, personal communication) and agrees with our predicted amino acid composition. These results establish the identified ORF as the structural gene for endonuclease IV.
Mapping the nfo promoter. Analysis of the DNA sequence 5' of the nfo gene revealed a potential promoter. To identify the in vivo site of transcriptional initiation, we mapped the nfo promoter by primer extension mapping of nfo transcripts. Cellular RNA from a strain bearing pRPC124 to enrich for nfo transcripts was used as a source of mRNA. A synthetic primer 17 nucleotides long complementary to nucleotides 122 through 138 was 5' 32p labeled, annealed to cellular RNA, and extended with reverse transcriptase. This primer was also annealed to an M13 clone carrying a portion of the antisense strand of the nfo gene, and a sequencing ladder was prepared by the dideoxy method. The DNA fragments extended by reverse transcriptase were displayed on a sequencing gel (Fig. 5) . The fragment generated from reverse transcription of the primer annealed to RNA (lane 5) ended at C48 (lane 4) with minor sites at G46 and G47 (lane 1) and A49 (lane 3). Since this is the sequence of the sense strand, transcription initiates at G48 with minor start sites at C46, C47, and T49. This start site is consistent with the location of the predicted promoter. DISCUSSION We sequenced the gene coding for endonuclease IV of E. coli. An ORF coding for a predicted polypeptide of 31,562 Da 
